factor κb ligand rankl Search Results


94
MedChemExpress rankl
Rankl, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/RANKL%2FTNFSF11%2C+Mouse/pmc12905433-52-0-14
Average 94 stars, based on 1 article reviews
rankl - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress human rankl
Human Rankl, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/RANKL%2FTNFSF11%2C+Human/pm42277334-147-0-3
Average 94 stars, based on 1 article reviews
human rankl - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
ProSci Incorporated rankl
Osteogenic compartment. a and b : Immunostaining for <t>RANKL.</t> At baseline (Bs) a few immunopositive cells are scattered within the compartment. At 18 h ( b ), RANKL+ cells were more numerous. The staining was stronger than at baseline. Bar = 50 μm. c Changes with time in RANKL+ cells. d Variations in osteogenic cells and osteocytes expressing semaphorin3a. e and f Immunostaining <t>for</t> <t>semaphorin</t> 3a. At baseline most osteogenic cells were immunopositive as were the osteocytes (arrows) subjacent to the bone surface. At 24 h, only a few cells expressed the marker while the osteocytes no longer expressed it. Bar = 50 μm. * p ≤ 0.05; ** p<0.01; *** p<0.005 versus baseline. ° p<0.02; °° p<0.003 versus 18 h. # p<0.05 versus 24 h.
Rankl, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/sRANK+Ligand+Antibody/pmc05714552-62-50-53
Average 90 stars, based on 1 article reviews
rankl - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
MedChemExpress rankl antibody denosumab
Osteogenic compartment. a and b : Immunostaining for <t>RANKL.</t> At baseline (Bs) a few immunopositive cells are scattered within the compartment. At 18 h ( b ), RANKL+ cells were more numerous. The staining was stronger than at baseline. Bar = 50 μm. c Changes with time in RANKL+ cells. d Variations in osteogenic cells and osteocytes expressing semaphorin3a. e and f Immunostaining <t>for</t> <t>semaphorin</t> 3a. At baseline most osteogenic cells were immunopositive as were the osteocytes (arrows) subjacent to the bone surface. At 24 h, only a few cells expressed the marker while the osteocytes no longer expressed it. Bar = 50 μm. * p ≤ 0.05; ** p<0.01; *** p<0.005 versus baseline. ° p<0.02; °° p<0.003 versus 18 h. # p<0.05 versus 24 h.
Rankl Antibody Denosumab, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/RANKL+Antibody/10__1038_slash_s41598___026___66895___2-202-13-19
Average 94 stars, based on 1 article reviews
rankl antibody denosumab - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Rockland Immunochemicals rank rankl pathway
Immunohistochemical staining.
Rank Rankl Pathway, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/RANKL+Human+Recombinant+Protein/pmc09750639-1-47-2
Average 93 stars, based on 1 article reviews
rank rankl pathway - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Boster Bio tnfsf11 rankl picokine elisa kit
Immunohistochemical staining.
Tnfsf11 Rankl Picokine Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/Mouse+TNFSF11%2FRANKL+ELISA+Kit+PicoKine/pmc09026232-164-31-35
Average 93 stars, based on 1 article reviews
tnfsf11 rankl picokine elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Boster Bio human tnfsf11 rankl elisa kit picokine
Immunohistochemical staining.
Human Tnfsf11 Rankl Elisa Kit Picokine, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/Human+TNFSF11%2FRANKL+ELISA+Kit+PicoKine/pmc08677805-147-21-27
Average 93 stars, based on 1 article reviews
human tnfsf11 rankl elisa kit picokine - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Boster Bio nuclear factor kb ligand
Immunohistochemical staining.
Nuclear Factor Kb Ligand, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/Mouse+TRANCE%2FRANK+L%2FTNFSF11+Recombinant+Protein/pm29454808-133-42-47
Average 93 stars, based on 1 article reviews
nuclear factor kb ligand - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio rankl primary antibody
Combined treatment (sCT+ASA) enhances <t>the</t> <t>OPG/RANKL</t> expression ratio in OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on mRNA levels in femur bone marrow cells from ovariectomized (OVX) rats. Gene expression was analyzed by reverse transcription-quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance with Student-Newman-Keuls analysis. (A) OPG; (B) RANKL; (C) mRNA expression ratio of OPG/RANKL. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand; mRNA, messenger RNA.
Rankl Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/Anti-sRANK+Ligand+TNFSF11+Antibody/pmc04464425-85-22-27
Average 90 stars, based on 1 article reviews
rankl primary antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
FUJIFILM receptor activator of nuclear factor κb ligand (rankl)
Combined treatment (sCT+ASA) enhances <t>the</t> <t>OPG/RANKL</t> expression ratio in OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on mRNA levels in femur bone marrow cells from ovariectomized (OVX) rats. Gene expression was analyzed by reverse transcription-quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance with Student-Newman-Keuls analysis. (A) OPG; (B) RANKL; (C) mRNA expression ratio of OPG/RANKL. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand; mRNA, messenger RNA.
Receptor Activator Of Nuclear Factor κb Ligand (Rankl), supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/receptor+activator+nuclear+factor+kappa+%CE%B2+ligand++rankl/pmc09795943-86-10-18
Average 90 stars, based on 1 article reviews
receptor activator of nuclear factor κb ligand (rankl) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EpimAb Biotherapeutics receptor activator of nuclear factor-κ b ligand (rankl) pathway
Combined treatment (sCT+ASA) enhances <t>the</t> <t>OPG/RANKL</t> expression ratio in OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on mRNA levels in femur bone marrow cells from ovariectomized (OVX) rats. Gene expression was analyzed by reverse transcription-quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance with Student-Newman-Keuls analysis. (A) OPG; (B) RANKL; (C) mRNA expression ratio of OPG/RANKL. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand; mRNA, messenger RNA.
Receptor Activator Of Nuclear Factor κ B Ligand (Rankl) Pathway, supplied by EpimAb Biotherapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/receptor+activator+of+nuclear+factor+%CE%BA+b+ligand++rankl++pathway/pm38836929-148-17-6
Average 90 stars, based on 1 article reviews
receptor activator of nuclear factor-κ b ligand (rankl) pathway - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
USCN Life receptor activator for nuclear factor kb ligand (rankl, immunoenzymatic assay)
Combined treatment (sCT+ASA) enhances <t>the</t> <t>OPG/RANKL</t> expression ratio in OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on mRNA levels in femur bone marrow cells from ovariectomized (OVX) rats. Gene expression was analyzed by reverse transcription-quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance with Student-Newman-Keuls analysis. (A) OPG; (B) RANKL; (C) mRNA expression ratio of OPG/RANKL. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand; mRNA, messenger RNA.
Receptor Activator For Nuclear Factor Kb Ligand (Rankl, Immunoenzymatic Assay), supplied by USCN Life, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/factor+%CE%BAb+ligand+rankl/rat+receptor+activator+of+nuclear+factor+kappa+b+ligand++rankl++elisa+kit/pm25706198-86-37-19
Average 90 stars, based on 1 article reviews
receptor activator for nuclear factor kb ligand (rankl, immunoenzymatic assay) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Osteogenic compartment. a and b : Immunostaining for RANKL. At baseline (Bs) a few immunopositive cells are scattered within the compartment. At 18 h ( b ), RANKL+ cells were more numerous. The staining was stronger than at baseline. Bar = 50 μm. c Changes with time in RANKL+ cells. d Variations in osteogenic cells and osteocytes expressing semaphorin3a. e and f Immunostaining for semaphorin 3a. At baseline most osteogenic cells were immunopositive as were the osteocytes (arrows) subjacent to the bone surface. At 24 h, only a few cells expressed the marker while the osteocytes no longer expressed it. Bar = 50 μm. * p ≤ 0.05; ** p<0.01; *** p<0.005 versus baseline. ° p<0.02; °° p<0.003 versus 18 h. # p<0.05 versus 24 h.

Journal: Heliyon

Article Title: Coordination of early cellular reactions during activation of bone resorption in the rat mandible periosteum: An immunohistochemical study

doi: 10.1016/j.heliyon.2017.e00430

Figure Lengend Snippet: Osteogenic compartment. a and b : Immunostaining for RANKL. At baseline (Bs) a few immunopositive cells are scattered within the compartment. At 18 h ( b ), RANKL+ cells were more numerous. The staining was stronger than at baseline. Bar = 50 μm. c Changes with time in RANKL+ cells. d Variations in osteogenic cells and osteocytes expressing semaphorin3a. e and f Immunostaining for semaphorin 3a. At baseline most osteogenic cells were immunopositive as were the osteocytes (arrows) subjacent to the bone surface. At 24 h, only a few cells expressed the marker while the osteocytes no longer expressed it. Bar = 50 μm. * p ≤ 0.05; ** p<0.01; *** p<0.005 versus baseline. ° p<0.02; °° p<0.003 versus 18 h. # p<0.05 versus 24 h.

Article Snippet: Mouse monoclonal antibodies against HIS48 (ref 554905, BD Biosciences Pharmingen, San Diego, CA, USA: 1:100), ED1 (murine equivalent of CD68, MAB1435, Chemicon, Temecula, CA, USA; 1:100), CD54 (ICAM-1, ref 554967, BD Biosciences Pharmingen, 1:50) and rabbit polyclonal antibodies against CD106 (VCAM-1, SC-8304, Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:50), RANKL (ref 3963, ProSci, Poway, CA, USA; 1/160), semaphorin 3a (ab23393, Abcam, Cambridge, UK; 1:50), laminin (L9393, Sigma; 1:25) were used.

Techniques: Immunostaining, Staining, Expressing, Marker

Immunohistochemical staining.

Journal: Medicine

Article Title: Determination of diagnostic and predictive parameters for vertical mandibular invasion in patients with lower gingival squamous cell carcinoma: A retrospective study

doi: 10.1097/MD.0000000000032206

Figure Lengend Snippet: Immunohistochemical staining.

Article Snippet: IL-6 , Rockland Inc. , 1:2000 , Rabbit polyclonal antibody , • Inflammatory cytokines released by cancer cells. • Since stimulation by IL-6 and TNF-α induces bone-resorbing multinucleated giant cells, it is possible that some mechanisms of the bone-resorptive effects of IL-6 are not mediated by the RANK/RANKL pathway..

Techniques: Immunohistochemical staining, Staining, Binding Assay, Activity Assay, Expressing

Combined treatment (sCT+ASA) enhances the OPG/RANKL expression ratio in OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on mRNA levels in femur bone marrow cells from ovariectomized (OVX) rats. Gene expression was analyzed by reverse transcription-quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance with Student-Newman-Keuls analysis. (A) OPG; (B) RANKL; (C) mRNA expression ratio of OPG/RANKL. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand; mRNA, messenger RNA.

Journal: Molecular Medicine Reports

Article Title: Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats

doi: 10.3892/mmr.2015.3637

Figure Lengend Snippet: Combined treatment (sCT+ASA) enhances the OPG/RANKL expression ratio in OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on mRNA levels in femur bone marrow cells from ovariectomized (OVX) rats. Gene expression was analyzed by reverse transcription-quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance with Student-Newman-Keuls analysis. (A) OPG; (B) RANKL; (C) mRNA expression ratio of OPG/RANKL. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand; mRNA, messenger RNA.

Article Snippet: The antibodies used were as follows: OPG primary antibody (1:80; BA1475; Wuhan Boster Biological Technology Co. Ltd., Wuhan, China; rabbit anti-rat OPG), RANKL primary antibody (1:80; BA1323; Wuhan Boster Biological Technology Co. Ltd.; rabbit anti-rat OPG ligand) and rabbit anti-rat biotinylated secondary antibody (SP-0023; Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China).

Techniques: Expressing, Gene Expression, Reverse Transcription, Real-time Polymerase Chain Reaction, Standard Deviation

Combined treatment significantly enhances the OPG/RANKL ratio in the proximal tibia of OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on protein expression levels in the proximal tibia of OVX rats. Specimens were observed at magnification, x250. Antigens were detected using an avidin-biotin-peroxidase system and visualized with 3,3′-diaminobenzidine. Protein levels were measured by densitometry. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance, with Student-Newman-Keuls analysis). (A) OPG; (B) RANKL; (C) OPG/RANKL protein ratio. Positive staining for OPG and RANKL was mainly localized in the chondrocytes of the epiphyseal growth plate and trabeculae of bone. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand.

Journal: Molecular Medicine Reports

Article Title: Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats

doi: 10.3892/mmr.2015.3637

Figure Lengend Snippet: Combined treatment significantly enhances the OPG/RANKL ratio in the proximal tibia of OVX rats. Effects of ASA, sCT and combined treatment (sCT+ASA) on protein expression levels in the proximal tibia of OVX rats. Specimens were observed at magnification, x250. Antigens were detected using an avidin-biotin-peroxidase system and visualized with 3,3′-diaminobenzidine. Protein levels were measured by densitometry. Values are expressed as the mean ± standard deviation. P-values were calculated by analysis of variance, with Student-Newman-Keuls analysis). (A) OPG; (B) RANKL; (C) OPG/RANKL protein ratio. Positive staining for OPG and RANKL was mainly localized in the chondrocytes of the epiphyseal growth plate and trabeculae of bone. ASA, aspirin; sCT, salmon calcitonin; OVX, ovariectomized; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor κB ligand.

Article Snippet: The antibodies used were as follows: OPG primary antibody (1:80; BA1475; Wuhan Boster Biological Technology Co. Ltd., Wuhan, China; rabbit anti-rat OPG), RANKL primary antibody (1:80; BA1323; Wuhan Boster Biological Technology Co. Ltd.; rabbit anti-rat OPG ligand) and rabbit anti-rat biotinylated secondary antibody (SP-0023; Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China).

Techniques: Expressing, Avidin-Biotin Assay, Standard Deviation, Staining